1. | | Recruiting | Anastrozole Compared With Tamoxifen After Lumpectomy in Treating Postmenopausal Women With Ductal Carcinoma in Situ Conditions: breast cancer in situ; intraductal breast carcinoma |
2. | | Recruiting | Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer Conditions: stage I colon cancer; adenocarcinoma of the colon |
3. | | No longer recruiting | Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed Conditions: stage II colon cancer; stage III colon cancer |
4. | | No longer recruiting | Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
5. | | No longer recruiting | Clodronate With or Without Chemotherapy and/or Tamoxifen in Treating Women With Stage I or Stage II Breast Cancer Conditions: stage I breast cancer; stage II breast cancer |
6. | | Not yet recruiting | Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer |
7. | | No longer recruiting | Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer and Positive Axillary Lymph Nodes Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
8. | | Completed | Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer Conditions: stage IIIB breast cancer; stage IV breast cancer; recurrent breast cancer |
9. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens With or Without Celecoxib in Treating Women With Breast Cancer Conditions: stage I breast cancer; stage II breast cancer |
10. | | No longer recruiting | Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; perioperative/postoperative complications |
11. | | Not yet recruiting | Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Women Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
12. | | Recruiting | Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 Conditions: stage II breast cancer; stage IIIA breast cancer |
13. | | Suspended | Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
14. | | No longer recruiting | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer Conditions: stage III colon cancer; stage II colon cancer |
15. | | Suspended | Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver Conditions: Colon Cancer; liver metastases; Rectal Cancer |
16. | | No longer recruiting | Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer Conditions: stage III colon cancer; stage I colon cancer; adenocarcinoma of the colon; stage II colon cancer |
17. | | No longer recruiting | Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer Conditions: stage I breast cancer; invasive ductal breast carcinoma; stage II breast cancer |
18. | | No longer recruiting | Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
19. | | No longer recruiting | Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Treating Women With Stage II Breast Cancer Condition: stage II breast cancer |
20. | | Recruiting | Radiation Therapy Following Surgery in Treating Women With Early-Stage Invasive Breast Cancer Conditions: stage I breast cancer; stage II breast cancer |
21. | | Recruiting | Radiation Therapy With Either Capecitabine or Fluorouracil Before Surgery in Treating Patients With Resectable Rectal Cancer Conditions: stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum |
22. | | No longer recruiting | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer Condition: Breast Cancer |
23. | | Recruiting | Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
24. | | Recruiting | Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer Conditions: stage I breast cancer; stage II breast cancer |
25. | | Recruiting | Therapy with docetaxel and ZD1839 for Patients who have advanced breast cancer Condition: Breast Neoplasms |